Daunorubicin Hydrochloride
Cat. No.：YN250443
CAS No. ：23541-50-6
| 产品名称: | Daunorubicin Hydrochloride |
| CAS No.: | 23541-50-6 |
| Chemical Name: | 8S-acetyl-10S-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione, monohydrochloride |
| Synonyms: | 盐酸柔红霉素; Daunomycin Hydrochloride; RP 13057 Hydrochloride; Rubidomycin Hydrochloride |
| 分子量: | 563.98 |
| 分子式: | C₂₇H₃₀ClNO₁₀ |
| SMILES: | O=C(C(C(OC)=CC=C1)=C1C2=O)C3=C2C(O)=C(C[C@@](O)(C(C)=O)C[C@@H]4O[C@@]5([H])C[C@H](N)[C@H](O)[C@H](C)O5)C4=C3O.[H]Cl |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Daunorubicin Hydrochloride (Daunomycin Hydrochloride; RP 13057 Hydrochloride; Rubidomycin Hydrochloride) 是具有有效抗肿瘤活性的DNA拓扑异构酶II。Daunorubicin Hydrochloride (Daunomycin Hydrochloride; RP 13057 Hydrochloride; Rubidomycin Hydrochloride) 抑制敏感和耐药的埃利氏腹水肿瘤细胞的DNA 和 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Laurent, G., and Jaffrézou, J.P.Signaling pathways activated by daunorubicinBlood98(4),913-924(2001)
Bose, R., Verheij, M., Haimovitz-Friedman, A., et al.Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell82(3),405-414(1995)
